Document:

EX-10.31

 

as of July 11, 2007           

ZBB Energy Corporation

N93 W14475 Whittaker Way

Menomonee Falls, WI 53051

Attention: Robert Parry

	 	Re: 	 	Convertible Loan Agreement (the “Agreement”) dated February 28, 2006
between ZBB Energy (the “Company”) and Montgomery Capital Partners
Ltd. (the “Investor”)

     Reference is made to the above referenced Agreement and separate letter agreements dated as
of October 5, 2006, as of March 13, 2007 and as of ___2007 (collectively, the
“Documents”). The Investor and the Company hereby intend to effect (a) a final payment
of all loan amounts and other financial obligations owed by the Company to the Investor and its
affiliates, including Cornell Capital Partners LP) under and in connection with the Documents,
and (b) issue certain securities of the Company to the Investor or its affiliates and designees
(collectively, the “Holders”).

1. Simultaneous with the execution and delivery of this letter agreement (the “Settlement
Agreement”), the Company shall pay to the Investor by wire transfer of immediately available
funds to an account designated by the Investor, the aggregate sum of $1,295,238.80 (the
“Settlement Payment”). Each of the Company and the Investor acknowledge and agree that
the Settlement Payment is comprised of:

• $890,000.00, representing the balance of unpaid principal amount due under the Loan
referred to in the Agreement;

• $124,917.80 in unpaid accrued interest on the Loan as at June 21, 2007 of $120,041,
plus $4,876.80, representing a per diem amount of $243.84 from June 22, 2007 to July 11, 2007;

• $178,000.00, representing an agreed upon premium payment under Clauses 6.3 and 6.4 of
the Agreement; and

• $102,321.00, representing the monthly deferral fee payable through June 21, 2007.

Each of the Investor and Cornell Capital Partners do hereby acknowledge and agree that payment
of the aforesaid Settlement Payment represents payment and performance in full by the Company of
all financial obligations owed to the Investor under the Documents.

101 Hudson Street – Suite 3700       Jersey City, NJ 07302       Tel: (201) 985-8300 / Facsimile: (201) 985-8266

 

 

2. On a date that shall be not more than 10 days from the date of this Agreement, the
Company shall issue to the Holder(s) stock certificates representing an aggregate of 265,937
shares of Company common stock (the “Shares”), and registered in the names of such Holder(s) as
shall be designated by the Investors. Such Shares are represented by:

• 202,674 unregistered and restricted Shares representing the Common Shares of the Company
issuable under Clause 7.4 of the Agreement (the “Clause 7.4 Shares”); and

• 63,263 unregistered and restricted Shares, representing Common Shares issuable upon a
“cashless exercise” as of July 5, 2007 of the additional subscription rights (warrants) granted
to the Investor under Clause 8 of the Agreement (the “Warrant Shares”).

The Company agrees that, within 30 days following completion of its audit report for the fiscal
year ending June 30, 2007, it (a) will file a registration statement with the Securities and
Exchange Commission (“SEC”) to register for resale at prevailing market prices all of the above
Shares, and (b) will use its best efforts to cause such registration statement to be declared
effective by the SEC as soon thereafter as is practicable. Each of the Holders whose shares are
included in such registration statement shall execute and deliver to the Company such
representations, warranties and indemnities with respect to their ownership and disclosures
concerning such Holders, as are customary in typical registrations of securities under the
Securities Act of 1933, as amended.

In addition, subject to compliance by the Company with its reporting requirements under the
Securities and Exchange Act of 1934, as amended and compliance by the Holder of the manner of
sale provisions and other provisions of Rule 144, upon written request of the Holder(s) the
Company will request its legal counsel to process and provide the necessary legal opinions to
permit (a) the immediate public resale of the Warrant Shares, and (b) the public resale of the
Clause 7.4 Shares within one year from the date of this Settlement Agreement, in the event that
the registration statement referred to in the immediately preceding paragraph has not been
declared effective by the SEC or is no longer current.

If the foregoing accurately reflects the substance of our mutual agreement and understanding,
please so indicate by executing and returning a copy of this Settlement Agreement in the space
provided below.

Very truly yours,

MONTGOMERY CAPITAL PARTNERS L.P.

	 	 	 	 	 
	By:
	 	 	 	 
	 

	 	 	 	 
	 

	 	Michael Rosselli, Managing Director
	 	 

-
2 - 101 Hudson Street – Suite 3700       Jersey City, NJ 07302      Tel: (201) 985-8300 / Facsimile: (201) 985-8266

 

 

ACCEPTED AND AGREED TO:

ZBB ENERGY CORPORATION

	 	 	 	 	 
	By:
	 	 	 	 
	 

	 	 	 	 
	 

	 	Robert Parry, President
	 	 

- 3 - 101 Hudson Street – Suite 3700       Jersey City, NJ 07302       Tel: (201) 985-8300 / Facsimile: (201) 985-8266EX-10.1

 

Exhibit
10.1

1991 INDEPENDENT DIRECTORS’ STOCK OPTION PLAN, AS AMENDED

     1. Purpose and Persons Covered. The purpose of the 1991 Independent
Directors’ Stock Option Plan, as amended, of Osteotech, Inc. is to provide
compensation to Independent Directors for joining and serving on the Board.

     2. Definitions.

	 	(a)	 	“Affiliate” shall have the meaning set forth in Rule 405 under the
Securities Act of 1933.
	 
	 	(b)	 	“Board” shall mean the Board of Directors of the Company.

	 
	 	(c)	 	“Change of Control” shall mean:

	 	(i)	 	a “Board Change” which, for purposes of this Agreement, shall
have occurred if a majority of the seats (not counting vacant
seats) on the Board were to be occupied by individuals who were
neither (A) nominated by a majority of the Incumbent Directors
nor (B) appointed by directors who were originally nominated by
a majority of the Incumbent Directors. An “Incumbent Director”
is a member of the Board who has been either (A) nominated by a
majority of the directors of the Company then in office or (B)
appointed by directors who were nominated by a majority of the
directors of the Company then in office, but excluding, for this
purpose, any such individual whose initial assumption of office
occurs as a result of either an actual or threatened election
contest (as such terms are used in Rule 14a-11 of Regulation 14A
promulgated under the Securities Exchange Act of 1934, as
amended (the “Exchange Act”)) or other actual or threatened
solicitation of proxies or consents by or on behalf of a person
other than the Board; or

 

	(1)	 	The Osteotech, Inc. 1991 Independent Directors’ Stock Option Plan, as
amended, was amended by the Board on October 22, 1992 and such amendment
was approved by the Stockholders on June 24, 1993; further amendments not
requiring Stockholder approval were approved by the Board on October 28,
1993; and further amendments were adopted by the Board on January 25, 1996
and approved by the Stockholders on June 6, 1996.

 

 

	 	(ii)	 	the acquisition by any individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a
“Person”) of beneficial ownership (within the meaning of Rule
13d-3 promulgated under the Exchange Act) of a majority of the
then outstanding voting securities of the Company (the
“Outstanding Company Voting Securities”); provided, however,
that the following acquisitions shall not constitute a Change of
Control: (A) any acquisition by the Company, (B) any acquisition
by any employee benefit plan (or related trust) sponsored or
maintained by the Company or any corporation controlled by the
Company or (C) any public offering or private placement by the
Company of its voting securities; or
	 
	 	(iii)	 	a merger or consolidation of the Company with another entity
that prior to the merger or consolidation was not a subsidiary
of the Company, where the Company shall not be the surviving
entity (a “Non-Surviving Merger”); or
	 
	 	(iv)	 	a merger or consolidation of the Company with another entity
that prior to the merger or consolidation was not a subsidiary
of the Company where the Company shall be the surviving entity,
but which results in the acquisition by a Person of a majority
of the Outstanding Company Voting Securities; or
	 
	 	(v)	 	a voluntary or involuntary liquidation of the Company (a
“Liquidation”); or
	 
	 	(vi)	 	a sale or disposition by the Company of at least 80% of its
assets in a single transaction or a series of transactions
(other than a sale or disposition of assets to a subsidiary of
the Company in a transaction not otherwise involving a Change of
Control of the Company or a change in control (as defined herein
with respect to the Company) of such subsidiary).

	 	(d)	 	“Code” shall mean the Internal Revenue Code of 1986, as amended.
	 
	 	(e)	 	“Common Stock” shall mean the $.01 par value Common Stock of the
Company.
	 
	 	(f)	 	“Company” shall mean Osteotech, Inc., a Delaware corporation.
	 
	 	(g)	 	“Disability” shall mean the condition of a member of the Board who is
unable to engage in any substantial gainful activity by reason of any
medically determinable physical or mental impairment which can be
expected to result in death or which has lasted or can be expected to
last for a continuous period of not less than twelve (12) months, all
within the meaning of Section 105(d)(4) of the Code.
	 
	 	(h)	 	“Exercise Price” shall mean the price per Share of Common Stock at
which an Option may be exercised.

2

 

	 	(i)	 	“Fair Market Value” of a Share of Common Stock as of a specified date
shall mean the closing price of a Share on the principal securities
exchange on which such Shares are traded on the day immediately
preceding the date as of which Fair Market Value is being determined,
or on the next preceding date on which such Shares are traded if no
Shares were traded on such immediately preceding day, or if the Shares
are not traded on a securities exchange, Fair Market Value shall be
deemed to be the average of the high bid and low asked prices of the
Shares in the over-the-counter market on the day immediately preceding
the date as of which Fair Market Value is being determined or on the
next preceding date on which such high bid and low asked prices were
recorded. If the Shares are not publicly traded, Fair Market Value
shall be determined by a nationally-recognized investment banking firm
retained by the Board.
	 
	 	(j)	 	“Independent Directors” shall mean members of the Board who are not
officers and/or employees of the Company.
	 
	 	(k)	 	“Option” shall mean a stock option granted pursuant to the Plan, which
option shall not be an Incentive Stock Option described in Code Section
422(A)(b).
	 
	 	(l)	 	“Optionee” shall mean a person to whom an Option has been granted.
	 
	 	(m)	 	“Plan” shall mean this Osteotech, Inc. 1991 Independent Directors’
Stock Option Plan, as amended.
	 
	 	(n)	 	“Purchase Price” shall mean the Exercise Price multiplied by the number
of whole Shares with respect to which an Option is exercised.
	 
	 	(o)	 	“Share” shall mean one share of Common Stock.

     3. Effective Date. This Plan was approved by the Board effective September
13, 1991 (the “Effective Date”).

     4. Grant of Options.

	 	(a)	 	Initial Grant. On the date each Independent Director is elected to the
Board such Independent Director shall be granted 10,000 Options.
	 
	 	(b)	 	Subsequent Grants. Upon each annual re-election of each Independent
Director to the Board by the Stockholders of the Company, such
Independent Director shall be granted 7,500 Options, provided such
Independent Director has served continuously on the Board during the
preceding year, and further provided that such Independent Director’s
initial election to the Board did not occur within six months prior to
such annual re-election. Upon an Independent Director’s initial
election as Chairman of the Board, such Independent Director shall
receive a one-time grant of 100,000 Options, in lieu of the grants
described in the preceding sentence and in Paragraph 4(a) above.
	 
	 	(c)	 	Elections not to receive. Notwithstanding the foregoing, an Independent
Director may irrevocably elect not to receive Options which he would
otherwise receive pursuant to subsections (a) or (b) hereof by
delivering written notice to the Board at least six (6) months in
advance of the date such Options would otherwise be granted; provided
that such Independent Director may receive nothing of value in lieu of
such grant.

3

 

     5. Stock. The stock subject to Options granted under the Plan shall be
Shares of authorized but unissued or reacquired Common Stock. The aggregate
number of Shares which may be issued under Options exercised under this Plan
shall not exceed 500,000. The number of Shares subject to Options outstanding
under the Plan at any time may not exceed the number of Shares remaining
available for issuance under the Plan. In the event that any Option
outstanding
under the Plan expires for any reason or is terminated, the Shares allocable to
the unexercised portion of such Option may again be subjected to an Option under
the Plan.

     The limitations established by this Section 5 shall be subject to
adjustment upon the occurrence of the events specified and in the manner
provided in Section 8 hereof.

     6. Terms and Conditions of Options. Options granted pursuant to the Plan
shall be evidenced by written agreements in the form attached hereto as Exhibit
A which agreements shall comply with and be subject to the following terms and
conditions:

	 	(a)	 	Date of Grant. Each Option shall specify its effective date (the “date
of grant”), which shall be the date the Option is granted in accordance
with Section 4 hereof.
	 
	 	(b)	 	Number of Shares. Each Option shall state the number of Shares to which
it pertains as specified by Section 4 hereof and shall provide for the
adjustment thereof in accordance with the provisions of Section 8
hereof.
	 
	 	(c)	 	Exercise Price. Each Option shall state the Exercise Price, which price
shall be the greater of: (i) the par value or (ii) the Fair Market
Value, of the Shares to which the Option relates on the date of grant.
	 
	 	(d)	 	Exercise of Options and Medium and Time of Payment. To exercise an
Option, the Optionee shall give written notice to the Company
specifying the number of Shares to be purchased and accompanied by
payment in cash or by certified check of the full Purchase Price
therefor, provided, however, that, with respect to any option granted
on or subsequent to July 1, 1997, an Optionee may, in lieu of the
payment of the Purchase Price in cash or by certified check, surrender
to the Company as payment of the Purchase Price of the Option, that
number of Shares of Common Stock issuable upon exercise of the Option,
with an aggregate Fair Market Value equivalent to the aggregate
Purchase Price of the Option being exercised. No Shares shall be
issued
until full payment therefor has been made in accordance herewith.
	 
	 	(e)	 	Term and Exercise of Options; Nontransferability of Options.

	 	(i)	 	Options granted prior to July 1, 1997. Options are not
exercisable for a period of one (1) year following the date of
grant. The Options shall thereafter be exercisable as follows:
25% of the Options will become exercisable on the first
anniversary of the date of grant; 25% of the Options will become
exercisable on the second anniversary of the date of grant; 25%
of the Options will become exercisable on the third anniversary
of the date of grant; and the remaining 25% of the Options will

4

 

	 	 	 	become exercisable on the fourth anniversary of the date the
Options become exercisable. The Options shall expire and no
longer be exercisable as of 5:00 p.m. local time at the location
of the Company’s principal executive offices (“local time”) on
the fifth anniversary of the date the Options become
exercisable. During the lifetime of the Optionee, the Option
shall be exercisable only by the Optionee and shall not be
assignable or transferable. In the event of the Optionee’s
death, no Option shall be transferable by the Optionee otherwise
than by will or by the laws of descent and distribution.

	 	(ii)	 	Options granted on or subsequent to July 1, 1997. Options vest
and become exercisable in their entirety one (1) year following
the date of grant. The Options shall expire and no longer be
exercisable as of 5:00 p.m. local time at the location of the
Company’s principal executive offices (“local time”) on the
tenth anniversary of the date of grant. During the lifetime of
the Optionee, the Option shall be exercisable only by the
Optionee and shall not be assignable or transferable. In the
event of the Optionee’s death, no Option shall be transferable
by the Optionee otherwise than by will or by the laws of descent
and distribution.

	 	(f)	 	Effect of Change of Control on Options.

	 	(i)	 	Options granted prior to July 1, 1997. Subject to any required
action by the stockholders of the Company, if the Company shall
be the surviving corporation in any merger or consolidation,
each outstanding Option shall pertain and apply to the
securities to which a holder of the number of Shares subject to
the Option would have been entitled in such merger or
consolidation. A dissolution or Liquidation of the Company or a
merger or consolidation in which the Company is not the
surviving corporation shall cause each outstanding Option to
terminate, unless the agreement of merger or consolidation shall
otherwise provide, provided that each Optionee shall, in such
event, have the right immediately prior to such dissolution or
Liquidation, or merger or consolidation in which the Company is
not the surviving corporation, if a period of one (1) year from
the date of the grant of the Option shall have elapsed, to
exercise the Option, in whole or in part, whether or not the
Optionee’s right to exercise such Option has otherwise accrued
pursuant to Section 6(e) of the Plan.
	 
	 	(ii)	 	Options granted on or subsequent to July 1, 1997. Subject to any
required action by the stockholders of the Company, if the
Company shall be the surviving corporation in any merger or
consolidation, each outstanding Option shall pertain and apply
to the securities to which a holder of the number of Shares
subject to the Option would have been entitled in such merger or
consolidation. Notwithstanding anything to the contrary
contained in the Option certificates or this Plan, the Options,
whether or not vested or earned at the time of any Change of
Control, shall immediately vest and become exercisable in

5

 

	 	 	 	accordance with their terms effective upon a Change of Control,
provided however that, in the case of a Non-Surviving Merger or
Liquidation, (A) such Options shall vest and become exercisable
in their entirety immediately prior to the effectiveness of such
Non-Surviving Merger or Liquidation, (B) such Optionee shall be
given the opportunity to exercise the Options prior to the
effectiveness of such Non-Surviving Merger or Liquidation and
(C) such Options shall terminate in their entirety to the extent
not previously exercised upon the effectiveness of such
Non-Surviving Merger or Liquidation.

	 	(g)	 	Termination.

	 	(i)	 	Options granted prior to July 1, 1997. Notwithstanding anything to
the contrary contained herein the Options shall expire and no
longer be exercisable as of 5:00 p.m. local time on (i) the day
the Independent Director is removed from the Board for cause in
accordance with the Company’s certificate of incorporation and
by-laws and the Delaware General Corporation Law; (ii) the
ninetieth (90th) day after the Independent Director (A)
voluntarily resigns from the Board (except as a result of the
Disability of such Independent Director), (B) is removed from the
Board without cause in accordance with the Company’s certificate
of incorporation and by-laws and the Delaware General Corporation
Law or (C) loses an election to the Board; or the (iii) first
anniversary of the date the Independent Director leaves the Board
due to his or her death or Disability.
	 
	 	(ii)	 	Options granted on or subsequent to July 1, 1997. Notwithstanding
anything to the contrary contained herein the Options shall expire
and no longer be exercisable as of 5:00 p.m. local time on (i) the
day the Independent Director is removed from the Board for
cause
in accordance with the Company’s certificate of incorporation and
by-laws and the Delaware General Corporation Law, or, (ii) in the
event that the Independent Director (A) voluntarily resigns from
the Board, (B) is removed from the Board without cause in
accordance with the Company’s certificate of incorporation and
by-laws and the Delaware General Corporation Law, (C) loses an
election to the Board or (D) leaves the Board due to his or her
death or Disability, the Option shall be exercisable for the
lesser of the term remaining for exercise of the Option or five
(5) years after the original date the Independent Director ceases
to be a member of the Board.

	 	(h)	 	Rights as a Stockholder. An Optionee or a transferee of a deceased
Optionee shall have no rights as a stockholder with respect to any
Shares covered by his or her Option until the date of the issuance of a
stock certificate for such Shares. No adjustment shall be made for
dividends (ordinary or extraordinary, whether in cash, securities or
other property) or distributions or other rights for which the record
date is prior to the date such stock certificate is issued, except as
provided in Section 8 hereof.

     7. Term of Plan. Options may be granted pursuant to the Plan until 5:00
p.m. local time on September 12, 2001.

6

 

     8. Recapitalization. Subject to any required action by the stockholders,
the number of Shares covered by this Plan as provided in Section 5, the number
of Shares covered by each outstanding Option, and the Exercise Price thereof
shall be proportionately adjusted for any increase or decrease in the number of
issued and outstanding Shares resulting from a subdivision or consolidation of
Shares, stock split, or the payment of a stock dividend.

     In the event of a change in the Common Stock as presently constituted,
which is limited to a change of all of the Company’s authorized shares with par
value into the same number of shares with a different par value or without
par
value, the shares resulting from any such change shall be deemed to be Shares of
Common Stock within the meaning of the Plan.

     Except as hereinbefore expressly provided in Section 6 or this Section 8,
the Optionee shall have no rights by reason of any subdivision or consolidation
of shares of stock of any class, stock split, or the payment of any stock
dividend or any other increase or decrease in the number of shares of stock of
any class or by reason of any dissolution, Liquidation, merger, or consolidation
or spin-off of assets or stock of another corporation, and any issue by the
Company of shares of stock of any class or securities convertible into shares of
stock of any class, shall not affect, and no adjustment by reason thereof shall
be made with respect to, the number or price of Shares subject to the Option.

     The grant of an Option pursuant to the Plan shall not affect in any way the
right or power of the Company to make adjustments, reclassifications,
reorganizations or changes of its capital or business structure or to merge or
consolidate or to dissolve, liquidate, sell or transfer all or any part of its
business or assets.

     9. Securities Law Requirements. No Shares shall be issued upon the exercise
of any Option unless and until the Company has determined that: (i) it and the
Optionee have taken all actions required to register the Shares under the
Securities Act of 1933 or perfect an exemption from the registration
requirements thereof; (ii) any applicable listing requirement of any stock
exchange on which the Common Stock are listed has been satisfied; and (iii) any
other applicable provision of state or Federal law has been satisfied.

     10. Amendment of the Plan. The Board may, insofar as permitted by law, from
time to time, with respect to any Shares at the time not subject to Options,
suspend or discontinue the Plan or revise or amend it in any respect whatsoever
except that (i) the provisions of Section 4 of the Plan may not be amended more
than once every six (6) months and (ii) without the approval of the stockholders
of the Company, no such revision or amendment shall:

	 	(a)	 	Increase the number of Shares subject to the Plan:
	 
	 	(b)	 	Materially modify the requirements as to eligibility for participation
in the Plan;
	 
	 	(c)	 	Materially increase the benefits accruing to participants under the
Plan; or
	 
	 	(d)	 	Amend this Section 10 to defeat its purpose.

     11. Application of Funds. The proceeds received by the Company from the
sale of Common Stock pursuant to the exercise of an Option will be used for
general corporate purposes.

7

 

     12. No Obligation to Exercise Option. The granting of an Option shall
impose no obligation upon the Optionee to exercise such Option.

     13. Withholding. Whenever Shares are to be delivered upon exercise of an
Option, the Company shall be entitled to require as a condition of delivery that
the Optionee remit to the Company an amount sufficient to satisfy the Company’s
federal, state and local withholding tax obligations with respect to the
exercise of the Option.

     14. Governing Law. The provisions of this Plan shall be governed and
construed in accordance with the laws of the State of New Jersey.

     15. Stockholder Approval. The Plan, and all Options granted hereunder from
the Effective Date through the date the Company’s stockholders approve the Plan,
shall be subject to approval and ratification by the Company’s stockholders. The
Plan shall be submitted to the Company’s stockholders at the next annual meeting
thereof held after the Effective Date.

8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}]]